Contact: Gina Kirchweger
Kirchweger@salk.edu
858-453-410-01340
Salk Institute

Combined Stem Cell-Gene Therapy Approach Cures Human Fenetic Disease In Vitro

Caption: Shown in green are genetically-corrected fibroblasts from Fanconi anemia patients are reprogrammed to generate induced pluripotent stem cells, which, in turn, can be differentiated into disease-free hematopoietic progenitors, capable of producing blood cells in vitro.

Credit: Courtesy of Dr. Juan-Carlos Belmonte, Salk Institute for Biological Studies

Usage Restrictions: News media reproduction to illustrate this story permitted with proper attribution as provided above. For one time use only.

Related news release: Combined stem cell-gene therapy approach cures human genetic disease in vitro